- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01818349
Impact of Training on Gait and Strength in Stroke Survivors
Gait Performance and Lower-limb Muscle Strength Improved in Both Upper-limb and Lower-limb Isokinetic Training Programs in Individuals With Chronic Stroke
Background: A discrepancy between strength gain and gait changes following various training programs aimed at improving gait function after stroke has been noted. A mismatch between the training program and gait parameters could explain this finding.
Objective: To evaluate the impact of an isokinetic-strengthening program, matching the requirements of the affected lower-limb muscle groups involved in the energy generation of gait, to a control intervention, on gait performance and muscle strength.
Hypothesis: The isokinetic training program of the affected lower-limb muscles would produce greater changes in gait performance and strength than a control intervention not aiming at training these muscle groups.
Design: Single-blinded randomized controlled trial.
Participants: A convenient sample of 30 individuals with chronic hemiparesis.
Interventions: Participants were randomly assigned into two groups (n=15), each training three times/week for six weeks. The experimental group trained the affected plantarflexors, hip flexors and extensors concentrically, while the control group trained the affected upper-limb muscles.
Main outcome measures: Baseline values and post-training values, taken at the end of the training program, of maximal voluntary concentric strength, gait speed and peak positive power.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Quebec
-
Montréal, Quebec, Canada, H3S 1M9
- Institut de réadaptation Gingras-Lindsay
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- have a chronic (six months or more) unilateral stroke
- be able to walk 10 meters independently with or without a cane
- present residual weakness at the affected lower limb
- have an activity tolerance of at least two hours with a rest period
Exclusion Criteria:
- receptive aphasia
- incontinence
- unstable medical condition
- history of injury
- anesthesia at the lower limbs
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: isokinetic lower-limb training
3 times/week for 6 weeks
|
concentric training of the affected plantarflexors, hip flexors and hip extensors
|
|
Placebo-vergelijker: isokinetic uppe-limb training
3 times/week for 6 weeks
|
concentric training of the affected wrist extensors, elbow flexors and shoulder flexors
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
change in gait speed
Tijdsspanne: gait speed was assessed at baseline and at the completion of the 6-week training (i.e. week #7)
|
change in gait speed, in meter/second, was assessed as the difference between the baseline and week #7 values.
|
gait speed was assessed at baseline and at the completion of the 6-week training (i.e. week #7)
|
|
change in peak positive power
Tijdsspanne: peak positive power was assessed at baseline and at the completion of the 6-week training (i.e. week #7)
|
peak positive power was evaluated at the affected plantarflexors, hip flexors and hip extensors.
Also, change in peak positive power, in weight/kilogram, was assessed as the difference between the baseline and week #7 values.
|
peak positive power was assessed at baseline and at the completion of the 6-week training (i.e. week #7)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
change in maximal voluntary concentric strength
Tijdsspanne: maximal voluntary concentric strength was assessed at baseline and at the completion of the 6-week training (i.e. week #7)
|
maximal voluntary concentric strength was evaluated at the affected plantarflexors, hip flexors and hip extensors.
Also, change in maximal voluntary concentric strength, in Newton-metre, was assessed as the difference between the baseline and week #7 values.
|
maximal voluntary concentric strength was assessed at baseline and at the completion of the 6-week training (i.e. week #7)
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Sylvie Nadeau, PhD, Université de Montréal
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- IRSC-44059
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .